title: [Progressive multifocal encephalopathy in a LED patient].
abstract: Progressive multifocal encephalopathy (PML) is a rare demyelinating disease of the central nervous system, caused by the reactivation of the JC virus in the body during immunosuppression. The use of monoclonal antibodies predisposes to PML, and the epidemiology of the disease has changed. We describe the first PML published from Finland and associated with rituximab treatment in a LED patient.
authors.forename: Tapani
authors.initials: T
authors.lastname: Tikkakoski
authors.forename: Sinikka
authors.initials: S
authors.lastname: Ingo
authors.forename: Lillemor
authors.initials: L
authors.lastname: Julin
authors.forename: Sven
authors.initials: S
authors.lastname: Kanckos
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D005387:Finland; D006801:Humans; D016867:Immunocompromised Host; D007155:Immunologic Factors / Q000009:adverse effects*; D007577:JC Virus; D007968:Leukoencephalopathy, Progressive Multifocal / Q000276:immunology* / Q000821:virology; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab